About LSBio
LSBio is a company based in Seattle (United States) founded in 1995 was acquired by Thompson Street Capital Partners in September 2018. LSBio has completed 4 acquisitions, including Absolute Antibody, Everest Biotech and Kerafast. LSBio offers products and services including Antibodies, ELISA Kits, and Proteins. LSBio operates in a competitive market with competitors including Abingdon Health, Olink, Spear Bio, US BioTek Laboratories and Correlia Biosystems, among others.
- Headquarter Seattle, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website lsbio.com
- Social LinkedIn X Facebook
- Acquired by Thompson Street Capital Partners (Sep 2018)
- Legal Name Lifespan Biosciences, Inc.
- Investors
- Investments & AcquisitionsAbsolute Antibody
& 3 more
- Acquired byThompson Street Capital Partners
(Sep 2018)
Products & Services of LSBio
LSBio offers a comprehensive portfolio of products and services, including Antibodies, ELISA Kits, and Proteins.
Monoclonal and polyclonal antibodies for protein detection in research
Kits for quantitative measurement of biological targets
Recombinant and native proteins for functional assays
Investors in LSBio
LSBio has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Thompson Street Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A private equity firm focused on middle-market business investments. | – | tscp.com | St. Louis, United States |
Investor details for LSBio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of LSBio
1 people are tracked at LSBio (1 in leadership).
| Name | Role | Group |
|---|---|---|
Heather Holemon | CEO | Leadership |
Complete people profiles for LSBio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by LSBio
LSBio has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Absolute Antibody, Everest Biotech and Kerafast.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Engineered antibodies are produced for research and diagnostics applications. | absoluteantibody.com | United Kingdom | 2012 | Dec 2020 | •••• | |
Bioreagents and research materials are supplied for life science research. | kerafast.com | Boston, United States | 2010 | Dec 2020 | •••• | |
Manufactures antibody and antibody related reagents | everestbiotech.com | Upper Heyford, United Kingdom | 2000 | Jul 2019 | •••• | |
Biotech company developing monoclonal antibodies and new biomarker targets for research | nordicmubio.com | Susteren, Netherlands | 2013 | Feb 2019 | •••• |
Complete acquisition details for LSBio
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of LSBio
6 dated milestones of LSBio across 25 years, from founding to its latest funding, stage changes and deals.
- Founded LSBio is founded.
- Exit Acquired by Thompson Street Capital Partners.
- Acquisition Acquires Nordic MUbio.
- Acquisition Acquires Everest Biotech.
- Acquisition Acquires Kerafast.
- Acquisition Acquires Absolute Antibody.
Competitors of LSBio
LSBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abingdon Health, Olink, Spear Bio, US BioTek Laboratories and Correlia Biosystems, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| abingdonhealth.com | 2008 | York, United Kingdom | $24.05M | 151 | Developer of immunoassays for diagnostic purposes | |
| olink.com | 2004 | Uppsala, Sweden | – | 138 | Provider of products and services for human protein biomarker research and development | |
| spear.bio | 2021 | Boston, United States | $48.96M | – | Developer of ultrasensitive immunoassays and proteomics platforms for detecting protein biomarkers | |
| usbiotek.com | 2008 | Shoreline, United States | $19.5M | – | Provider of enzyme-linked immunosorbent assay technology services | |
| correliabio.com | 2013 | Berkeley, United States | $10.95M | – | Correlia Biosystems is focused on protein quantification technology. | |
| eclipsebio.com | 2017 | San Diego, United States | $14M | 14 | Cell-free immunoassays are developed to identify RNA binding protein targets. | |
| virtuedx.com | 2019 | Suzhou, China | $130M | – | An in vitro assay platform is provided for diagnostic solutions. | |
| accellix.com | 2007 | San Jose, United States | $35.84M | – | Developer of immunotherapy-based assay delivery platform | |
| procisedx.com | 2018 | San Diego, United States | $8.96M | – | Point-of-care diagnostic devices for immunoassay tests are provided to clinicians. | |
| orbitdiscovery.com | 2015 | Oxford, United Kingdom | $15.73M | 26 | Drug discovery platform developed using peptide display engine. |
Detailed competitors of LSBio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of LSBio
The website of LSBio (lsbio.com) receives about 41.5K visits a month.
- Monthly visits41.5K
▼ 22.8% vs previous month
Websites whose visitors overlap most with LSBio. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| abcam.com | 100% | 602.8K | #91,958 | View details | |
| abnova.com | 95% | 30.7K | #957,320 | View details | |
| raybiotech.com | 89% | 71.1K | #537,358 | View details | |
antibodyresource.com | antibodyresource.com | 88% | – | #6,501,729 | – |
acris-antibodies.com | acris-antibodies.com | 86% | – | #11,446,421 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for LSBio
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Lsbio
Complete news archive for LSBio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to LSBio
10 companies that operate in the same segment as LSBio (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about LSBio
LSBio was founded in 1995.
LSBio is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
LSBio was founded in 1995 in Seattle, United States, and operates in the biotechnology sector focused on immunology. Reagents and kits, including primary and secondary antibodies, isotype controls, recombinant proteins, ELISA kits, and immunohistochemistry reagents, are developed and manufactured. Services such as immunohistochemistry and TCR screening are also provided to support research applications.
LSBio's top competitors include Abingdon Health, Eclipse Bio and Spear Bio.
LSBio offers Antibodies, ELISA Kits, and Proteins.
LSBio has made 4 acquisitions, including Absolute Antibody, Everest Biotech, and Kerafast.
LSBio has 1 investor. Key investors include Thompson Street Capital Partners.
LSBio operates through Lifespan Biosciences, Inc..
Yes. LSBio was acquired by Thompson Street Capital Partners in September 2018.